SILVER SPRING, Md. and
RESEARCH TRIANGLE PARK, N.C.,
Aug. 3, 2021 /PRNewswire/
-- United Therapeutics Corporation (Nasdaq: UTHR) announced
today that Martine Rothblatt, Ph.D.,
Chairperson and Chief Executive Officer of United Therapeutics,
will provide an overview and update on the company's business
during a fireside chat session at the 2021 Wedbush PacGrow
Healthcare Virtual Conference.
The session will take place virtually on Wednesday, August 11, 2021, from 8:35 a.m. to 9:05 a.m., Eastern Daylight Time,
and can be accessed via a live webcast on the United Therapeutics
website at https://ir.unither.com/events-and-presentations. An
archived, recorded version of the session will be available
approximately 24 hours after the session ends and can be accessed
at the same location for 90 days.
United Therapeutics: Enabling Inspiration
United Therapeutics Corporation focuses on the strength of a
balanced, value-creating biotechnology model. We are confident in
our future thanks to our fundamental attributes, namely our
obsession with quality and innovation, the power of our brands, our
entrepreneurial culture, and our bioinformatics leadership. We also
believe that our determination to be responsible citizens – having
a positive impact on patients, the environment, and society – will
sustain our success in the long term.
Through our wholly owned subsidiary, Lung Biotechnology PBC, we
are focused on addressing the acute national shortage of
transplantable lungs and other organs with a variety of
technologies that either delay the need for such organs or expand
the supply. Lung Biotechnology is the first public benefit
corporation subsidiary of a public biotechnology or pharmaceutical
company.
Please visit unither.com to learn more.
Forward-Looking Statements
Statements included in this press release that are not historical
in nature are "forward-looking statements" within the meaning of
the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include, among others, statements
relating to our ability to create value and sustain our success in
the long-term, as well as our efforts to develop technologies that
either delay the need for transplantable organs or expand the
supply of transplantable organs. These forward-looking statements
are subject to certain risks and uncertainties, such as those
described in our periodic reports filed with the Securities and
Exchange Commission, that could cause actual results to differ
materially from anticipated results. Consequently, such
forward-looking statements are qualified by the cautionary
statements, cautionary language, and risk factors set forth in our
periodic reports and documents filed with the Securities and
Exchange Commission, including our most recent Annual Report on
Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on
Form 8-K. We claim the protection of the safe harbor contained in
the Private Securities Litigation Reform Act of 1995 for
forward-looking statements. We are providing this information as of
August 3, 2021 and assume no
obligation to update or revise the information contained in this
press release whether as a result of new information, future events
or any other reason.
For Further Information Contact:
Dewey Steadman at (202) 919-4097
Email: ir@unither.com
View original
content:https://www.prnewswire.com/news-releases/united-therapeutics-corporation-to-present-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference-301346110.html
SOURCE United Therapeutics Corporation